ArticleScientific reports2025

Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy.

Chunhuan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.